Two doses of BNT162b2 moderately effective for 5- to 11-year-olds - Medical Xpress
6/30/2022 12:00:00 AM2 years 10 months ago
by Science X staff
by Science X staff
For children aged 5 to 11 years, two doses of BNT162b2 provide moderate protection against documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and symptomatic COVID-19, according to a study published online June 29 in the New Eng…
For children aged 5 to 11 years, two doses of BNT162b2 provide moderate protection against documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and symptomatic COVID-19, … [+2150 chars]
full article...